Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 5, 2009, Pages 341-346

  Stanojevic, Marijana ^a   Savin, Svetlana ^b   Cvejic, Dubravka ^b   Djukic, Aleksandar ^a   Jeremic, Marija ^c   Simonovic, Snezana Zivancević ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CLINICAL CENTRE KRAGUJEVAC   (Serbia)

Author keywords

Antithyroglobulin autoantibodies; Differentiated thyroid cancer; Immunoradiometric assay; Radioimmunoassay; Thyroglobulin

Indexed keywords

THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ARTICLE; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; IMMUNORADIOMETRIC ASSAY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PATIENT MONITORING; POSTOPERATIVE PERIOD; RADIOIMMUNOASSAY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA;

ANTIBODIES, NEOPLASM; HUMANS; IMMUNORADIOMETRIC ASSAY; RADIOIMMUNOASSAY; REFERENCE VALUES; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 70349556160     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20339     Document Type: Article

References (32)

1. Demers LM, Spencer CA 7-13-2002 Laboratory support for the diagnosis and monitoring of thyroid disease. http://www.nacb.org/ lmpg/thyroidLMPG.stm.
2. Mazzaferri EL, Robbins RJ, Spencer CA, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003;88:1433-1441. (Pubitemid 36623351)
3. Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998;83:1121-1127. (Pubitemid 28496379)
4. Spencer CA, Wang CC. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls. Endocrinol Metab Clin North Am 1995;24:841-863.
5. Clark PM, Beckett G. Can we measure serum thyroglobulin? Ann Clin Biochem 2002;39:196-202.
6. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyroglobulin assays. Clin Chem 1996;42:164-173. (Pubitemid 26030404)
7. Spencer CA, Bergoglio LM, KazarosyanM, Fatemi S, LoPresti JS. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005;90: 5566-5575. (Pubitemid 41415459)
8. Tortajada Genaro LA, Cozar MP,Moreno Frigols JL, Romero de Avila C. Comparison of immunoradiometric assays for determination of thyroglobulin: A validation study. J Clin Lab Anal 2007;21:147-153.
9. Black EG Hoffenberg R. Should one measure serum thyroglobulin in the presence of anti-thyroglobulin antibodies? Clin Endocrinol 1983;19:597-601.
10. Mariotti S, Barbesino G, Caturegli P, et al. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: An unobtainable goal? J Clin Endocrinol Metab 1995;80:468-472.
11. Massart C Maugendre D. Importance of the detection method for thyroglobulin antibodies for the validity of thyroglobulin measurements in sera from patients with Graves' disease. Clin Chem 2002;48:102-107.
12. Stanojević M, Savin S, Cvejić D, Cross Dsignukić A, Živančević Simonović S. Correlation of thyroglobulin concentrations measured by radioimmunoassay and immunometric assay and the influence of thyroglobulin antibody. J Immunoassay Immunochem 2009;30: 197-207.
13. Spencer CA. J Editorial: Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. Clin Endocrinol Metab 2004;89:3702-3704.
14. Spencer CA, Wang C, Fatemi S, Guttler RB, Takeuchi M Kazarosyan M. Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998;83:1121-1127. (Pubitemid 28496379)
15. Cubero JM, Rodriques-Espinosa J, Gelpi C, Estorch M, Corcoy R. Thyroglobulin autoantibody levels below the cut-off positivity can interfere with thyroglobulin measurement. Thyroid 2003;13:659-661. 16. http://www.medicrit.com/libros/TIROIDES/6a.pdf. (Pubitemid 36993562)
16. Stanojević M, Petrović M, Cross Dsignukić A, Savin S, Dimitrijević Lj, Živančević Simonović S. Uticaj antitireoglobulinskih antitela na koncentraciju tireoglobulina izmerenu imunoradiometrijskim testom. Medicinski časopis 2007;41:1.
17. Spencer CA. Recoveries cannot be used to authenticate thyroglobulin (Tg) measurements when sera contain Tg autoantibodies. Clin Chem 1996;42:661-663.
18. Ferrari L, Biancolini D, Seregni E, et al. Critical aspects of immunoradiometric thyroglobulin assays. Tumori 2003;89:537-539. (Pubitemid 37541613)
19. Schultz R, Bethauser H, Stempka L, Heilig B, Moll A, Hufner M. Evidence for immunological differences between circulating and tissue-derived thyroglobulin in men. J Clin Invest 1989;19:459-463.
20. Kumar A, Shah Dh, Shrihari U, Dandekar SR, Vijayan U, Sharma SM. Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma. Thyroid 1994;4:199-202. (Pubitemid 24202356)
21. Rubello D, Casara D, Girelli ME, Piccolo M, Busnardo B. Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: A prospective study. J Nucl Med 1992;33:1478-1480.
22. Lukinac Lj, Krilić D, Nothing-Hus D, Kusić Z. The problem of thyroid antibodies testing. Acta Clin Croat 2004;43:355-359.
23. Kohse KP, Wisser H. Antibodies as a source of analytical errors. J Clin Chem Biochem 1990;28:881-892.
24. Görges R, Maniecki M, Jentzen W, et al. Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol 2005;153:49-55. (Pubitemid 41030515)
25. Feldt-Rasmussen U, Rasmussen AK. Serum thyroglobulin in presence of thyroglobulin autoantibodies in vitro and in vivo. Clinical and methodological relevance. J Clin Invest 1985;8: 571-576.
26. Schneider AB, Pervos R. Radioimmunoassay of human thyroglobulin: Effect of antithyroglobulin autoantibodies. J Clin Endocrinol Metab 1978;47:126-137. (Pubitemid 8371253)
27. Schaadt B, Feldt-Rasmussen U, Rasmusson B, et al. Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma. Thyroid 1995;5:165-170.
28. Feldt-Rasmussen U, Schlumberger M. European interlaboratory comparison of serum thyroglobulin measurement. J Endocrinol Invest 1988;11:175-181.
29. Spencer CA, LoPresti JS, Fatemi S, Nicoloff JT. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement. Thyroid 1999;9:435-441. (Pubitemid 29244919)
30. Spencer CA. New insights for using serum thyroglobulin (Tg) measurement for managing patients with differentiated thyroid carcinomas. Thyroid Int 2003;4:1-14.
31. Baloch Z, Carayon P, Conte-Devolx B, et al. Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13: 3-126.
32. Pacini F, Mariotti S, Formica N, Elisei R. Thyroid autoantibodies in thyroid cancer: Incidence and relationship with tumor outcome. Acta Endocrinol 1988;119:373-380. (Pubitemid 18274831)